Ultrasound-Targeted Microbubble Destruction (UTMD) for Localized Drug Delivery into Tumor Tissue |
| |
Authors: | J. Wischhusen F. Padilla |
| |
Affiliation: | 1. Univ Lyon, Université Lyon 1, Centre Léon Bérard, INSERM, LabTAU, F-69003, Lyon, France;2. Apoptosis, Cancer and Development Laboratory – Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052–CNRS UMR5286, Centre Léon Bérard, 69008 Lyon, France;3. Focused Ultrasound Foundation, Charlottesville, USA;4. Department of Radiation Oncology, School of Medicine, University of Virginia, USA |
| |
Abstract: |
BackgroundUltrasound-targeted microbubble destruction (UTMD) is a type of ultrasound therapy, in which low frequency moderate power ultrasound is combined with microbubbles to trigger cavitation. Cavitation is the process of oscillation of gas bubbles causing biophysical effects such as pushing and pulling or shock waves that permeabilize biological barriers. In vivo, cavitation results in tissue permeabilization and is used to enable local delivery of nanomedicine. While cavitation can occur in biological liquids when high pressure ultrasound is applied, the use of microbubbles as cavitation nuclei in UTMD largely facilitates the induction of cavitation. UTMD is intensively studied for drug delivery into tumor tissue, but also for the activation of anti-tumor immune responses. The first clinical studies of UTMD-mediated chemotherapy delivery confirmed safety and efficacy of this approach.AimThe present review summarizes ultrasound settings, cavitation approaches, biophysical mechanisms of drug delivery, drug carriers, and pre-clinical and clinical applications of UTMD for drug delivery into tumors. |
| |
Keywords: | Correspondence to: Apoptosis Cancer and Development Laboratory Centre de Cancérologie de Lyon INSERM U1052–CNRS UMR5286 Centre Léon Bérard 28 rue Laënnec 69008 Lyon France. |
本文献已被 ScienceDirect 等数据库收录! |
|